markers measured ( Figure 1C ). This phenotype represented the sole AF cell type identified thus far. Conclusions: We generated the first human annulus fibrosis cell lines and present an detailed characterization of their phenotype in comparison to our novel nucleus pulposus cell lines. The distinct migratory behavior of isolated immortal AF clones, in contrast to that of cell pools, suggests that distinct phenotype may be preferentially immortalized and, by inference, that functionally different subtypes may exist in AF cell population. Our future investigations will focus on integrin expression, in relation to culturing them on defined (e.g. fibronectin, collagen) surfaces, as such conditions were suggested to mimic AF-like conditions.
Background/Purpose: Mohawk homeobox (MKX) has been demonstrated as a tendon and ligament specific transcriptional factor. MKX knock-out mice showed hypoplastic tendons throughout the body, due to reduced type I collagen production in tendon cells. However, in mature human tendon or ligament tissues, the function of MKX has not been fully understood. The aims of this study are to characterize the expression of MKX in normal human knee joints and osteoarthritis (OA) affected knee joints and to investigate the role of MKX in human ligament homeostasis and in ligament/tenogenic differentiation of mesenchymal stem cells. Methods: Human ACL specimens were obtained from the knee joints at autopsy within 24-48 hours postmortem with approval of the Scripps Human Subjects Committee. 7 normal donors (mean AE SD age 33.6 AE 11.7 years) and 8 donors with OA (mean AE SD age 77.5 AE 11.5 years) were analyzed. All cartilage surfaces were graded macroscopically. ACL degeneration was assessed macroscopically and histologically using quantitative scoring systems. ACL tissues were analyzed for the expression of MKX by immunohistochemistry and quantitative RT-PCR assays. Primary cultured human ACL cells were stimulated with IL-1b to examine whether this pro-inflammatory cytokine modulates MKX expression. Moreover, in order to examine the function of MKX in ECM production and differentiation in these cells, we performed MKX knockdown by MKX specific siRNA. To examine the function of MKX in ECM production and differentiation in human bone marrow mesenchymal stem cells (BMMSC) (n¼6 from 2 donors), we performed over-expression of MKX by adenoviral vector and analyzed gene and protein levels of COL1a1, and tenascin b (TNXb), important ECM components of ACL.
Results: The expression of MKX mRNA was remarkably decreased during OA development. In addition, the expression of COL1a1 was also decreased in the OA group. Immunohistochemistry revealed that the percentage of MKX positive cells was significantly reduced in OA group. In primary cultured human ACL cells, the expression of MKX was significantly reduced by the treatment of IL-1b. The expression of ECM genes COL1a1 and TNXb and transcription factor Scleraxis (SCX), which is a specific regulator of the tendon/ligament lineage, were downregulated by IL-1b treatment. On the other hand, SOX9, which is involved in the modulation of chondrocyte like phenotype, was upregulated by IL-1b treatment. The expression of COL1a1 and TNXb were decreased by MKX specific siRNA treatment, while SOX9 was increased. By contrast, the expression of COL1a1 and TNXb were increased by overexpression of MKX in BMMSCs. Conclusion: To our knowledge, this is the first report to investigate the MKX expression and function in human ligaments. The present findings demonstrate that the ACL in OA-affected joints are deficient in MKX expression and this is associated with reduced ECM production. Reduced MKX in OA may be due to inflammatory stimuli such as IL-1b. In cultured ACL cells, and in mesenchymal stem cells MKX promotes the maintenance and induction of tenocyte phenotype. Thus, MKX is a key factor that is required for maintenance of ligament structure and function.
GENE EXPRESSION VARIATION IN HUMAN MENISCUS: MOLECULAR AND CLINICAL IMPLICATIONS FOR CARTILAGE HOMEOSTASIS AND EARLY OSTEOARTHRITIS DEVELOPMENT
Purpose: Meniscal tears may be critical indicators of future osteoarthritis. Our objective was to ascertain the metabolic state of the tissue at the time of arthroscopic surgery to repair the meniscus. Transcriptome analysis of the meniscal tissues was performed to probe the molecular profile related to age and arthritic changes in articular cartilage. Methods: Human meniscus tissues were acquired from patients (n¼12) undergoing arthroscopic partial meniscectomy. The degree of chondrosis of articular cartilage was recorded at the time of arthroscopic meniscal resection. RNA preparations from these meniscal tissues were subjected to microarray analysis followed by validation of fold-change differences by QuantiGene Plex assay. The fold-change variation in gene expression was computed for either age (young versus old) or presence or absence of chondrosis and the relevant biological processes were investigated computationally. Results: We identified, for the first time, a set of comprehensive, differentially expressed genes from resected meniscus tissues. The population of differentially regulated genes identified differed with age or degree of chondrosis. We identified 866 genes differentially regulated (>1.5-fold; P< 0.05) by age (373 up; 493 down) and 49 genes by degree of chondrosis (23 up; 26 down). Notably, a number of biologically significant genes down-regulated with age are extracellular matrix genes such as COL2A1 (10.38-fold), CHAD (6.73-fold), COL11A2 (6.14fold), COL9A2 (5.99-fold), CILP2 (4.32-fold) and ACAN (2.52-fold), which is suggestive of degenerative changes in the meniscus with age. Some of the genes upregulated with age include immune response and inflammation genes [HLA-DRB5 (15.73-fold), HLA-DRB1 (15.01-fold), IL-7R (2.83-fold), CX3CR1 (2.28-fold), CCL8 (1.56-fold)] and cell proliferation genes [DLGAP5 (2.38-fold), PCNA (1.63-fold), CDC25C (1.61-fold)]. The gene expression data was used to generate functional and molecular networks using Gene Relational Network of InterActing Elements (GRANITE) and the resulting gene interactions are shown in the Figure. The network analysis shows that differentially expressed genes are linked with each other indicating their plausible contribution in similar pathways. Taken, together our data suggest that age-related decrease in matrix synthesis and increase in inflammatory events may promote degenerative meniscal tears with subsequent chondral changes ultimately leading to osteoarthritis development. Conclusions: Transcriptome analysis identified definitive subtypes of meniscal damage that could be segregated molecularly by age or degree of chondrosis. These studies provide a molecular link between meniscal damage and cartilage degeneration. Objective: SirT1 is a nuclear NAD-dependent deacetylase associated with cell metabolism and survival. In joints, recent evidence shows that it regulates cartilage homeostasis and is involved in the inflammatory phase of osteoarthritis (OA). It is widely held that the inflammatory cytokines tumor necrosis factor alpha (TNFa), and interleukin 1b (IL-1b) may elicit chondrocyte death associated with the deterioration of articular cartilage (AC) in OA. Exposing human chondrocytes to both cytokines leads to cathepsin B-mediated cleavage of the nuclear full-length SirT1 (FLSirT1; 110kDa) to generate a stable but enzymatically inactive 75kDa fragment of SirT1 (75SirT1). Here we aim to elucidate the biological and biochemical role of 75kDa SirT1 fragment in-vivo and in-vitro Methods: Using immunoblot analyses we aimed to detect cathepsin B, FLSirT1 and/or 75SirT1 in OA and normal human chondrocytes. Confocal imaging of SirT1 was used to monitor its subcellular trafficking following TNFa stimulation of human chondrocytes. Coimmunofluorescent staining for cathepsin B, mitochondrial cytochrome oxidase subunit IV and lysosome-associated membrane protein 1 together with SirT1 was performed. Human chondrocytes were tested for apoptosis by fluorescence-activated cell sorter analysis and immunoblotting for caspases 3 and 8. Human chondrocyte mitochondrial extracts were obtained and analyzed for 75SirT1-cytochrome C association. In-vivo assays of heterozygous haploinsufficient (SirT1+/-) and wildtype (WT; SirT1+/+) 129/J mice aged 1 or 9 months were systematically compared for musculoskeletal features, scored for osteoarthritis (OA) severity, and monitored for chondrocyte apoptosis in articular cartilage. Protein extracts from articular chondrocytes were isolated and immunoblotted for SirT1 and active caspase 3. Results: Confocal imaging, immunoprecipitation assays and immunoblot analyses following TNFa challenge of human chondrocytes exhibited that 75SirT1 was generated and exported to the cytoplasm wherein it colocalized with the mitochondrial membrane and associates with cytochrome C. Additionally, levels of cathepsin B and 75SirT1 were elevated in OA versus normal chondrocytes. Subjecting human chondrocytes to TNFa and a cathepsin B inhibitor (ALLN), enhanced levels of apoptotic cell and cleaved caspase 3. Immunoblot assays comparing medial tibial plateau articular cartilage (MTP-AC) of heterozygous haploinsufficient (SirT1+/-) and wild-type (WT; SirT1+/+) 129/J mice revealed reduced levels of FLSirT1 in both strains at 9 months compared to their 1 month equivalent. WT 9-monthold strains presented the 75SirT1 fragments in immunoblot assays, whereas age-matched SirT1+/-mice possessed undetected 75SirT1 levels. Interestingly, 9 month-old SirT1+/-mice exhibited increased OA severity and augmented levels of apoptosis compared with age-matched WT mice. Conclusion: Despite 75SirT1 being enzymatically impaired our results show that it is relatively stable and participates in promoting chondrocyte survival following exposure to proinflammatory cytokines or during articular cartilage maturation. 
